Roth Capital Resumes Acadia Pharmaceuticals (ACAD) at Neutral

October 19, 2016 8:12 AM EDT
Get Alerts ACAD Hot Sheet
Price: $27.30 -3.36%

Rating Summary:
    9 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 20 | Down: 30 | New: 24
Trade ACAD Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Roth Capital resumed coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with a Neutral rating.

For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.

Shares of Acadia Pharmaceuticals closed at $24.33 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment